Tenaya Therapeutics Inc (TNYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 10,452 | 8,872 | 9,266 | 0 |
| Operating Income | -10,452 | -8,872 | -9,266 | N/A |
| Other Income | 157 | 141 | 215 | 0 |
| Pre-tax Income | -10,295 | -8,731 | -9,051 | 0 |
| Net Income Continuous | -10,295 | -8,731 | -9,051 | N/A |
| Net Income | $-10,295 | $-8,731 | $-9,051 | $N/A |
| EPS Basic Total Ops | -10.29 | -9.21 | -10.15 | N/A |
| EPS Basic Continuous Ops | -10.30 | -9.21 | -10.15 | N/A |
| EPS Diluted Total Ops | -10.29 | -9.21 | -10.15 | N/A |
| EPS Diluted Continuous Ops | -10.30 | -9.21 | -10.15 | N/A |
| EBITDA(a) | $-9,821 | $-8,262 | $-8,682 | $N/A |